Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ESMO Magnitude of Clinical Benefit Scale (MCBS)

Dr Nazik Hammad - University of Toronto, Toronto, Canada
ESMO Magnitude of Clinical Benefit Scale (MCBS) ( Dr Nazik Hammad - University of Toronto, Toronto, Canada )
20 Jan 2025

Enhancing patient safety: The critical role of pharmacovigilance in oncology

Dr Lucas K Nyabero - Health Innovations Inc. Massachusetts/College of Pharmacy and Health Sciences, Nairobi, Kenya.
Enhancing patient safety: The critical role of pharmacovigilance in oncology ( Dr Lucas K Nyabero - Health Innovations Inc. Massachusetts/College of Pharmacy and Health Sciences, Nairobi, Kenya. )
20 Jan 2025

The AMPATH multiple myeloma programme model

Ms Mercy Oduor - AMPATH Kenya, Eldoret, Kenya
The AMPATH multiple myeloma programme model ( Ms Mercy Oduor - AMPATH Kenya, Eldoret, Kenya )
20 Jan 2025

Reflections after the ecancer Tata Medical Center, Kolkata Psycho-oncology congress 2024

Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India
Reflections after the ecancer Tata Medical Center, Kolkata Psycho-oncology congress 2024 ( Dr Soumitra Shankar Datta - Tata Medical Centre, Kolkata, India )
15 Jan 2025

The long-standing partnership between Tata Medical Center, Kolkata and ecancer Global Foundation

Dr Pattatheyil Arun - Tata Medical Centre, Kolkata, India
The long-standing partnership between Tata Medical Center, Kolkata and ecancer Global Foundation ( Dr Pattatheyil Arun - Tata Medical Centre, Kolkata, India )
15 Jan 2025

Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed multiple myeloma

Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston, USA
Isatuximab survival benefit over VRd in transplant-ineligible newly diagnosed multiple myeloma ( Prof Robert Orlowski - University of Texas MD Anderson Cancer Center, Houston, USA )
14 Jan 2025

SABCS 2024: Highlights in breast cancer genomic testing

Prof Matteo Lambertini and Prof Virginia Kaklamani
SABCS 2024: Highlights in breast cancer genomic testing ( Prof Matteo Lambertini and Prof Virginia Kaklamani )
23 Dec 2024

The use of IORT at Montefiore Medical Center

Dr Sheldon Feldman - Montefiore Einstein Comprehensive Cancer Center, New York, USA
The use of IORT at Montefiore Medical Center ( Dr Sheldon Feldman - Montefiore Einstein Comprehensive Cancer Center, New York, USA )
19 Dec 2024

HER3-DXd demonstrates similar efficacy compared to multi-agent chemotherapy in high-risk HR-positive/HER2-negative eBC

Dr Mafalda Oliveira - Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
HER3-DXd demonstrates similar efficacy compared to multi-agent chemotherapy in high-risk HR-positive/HER2-negative eBC ( Dr Mafalda Oliveira - Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
19 Dec 2024

Special Issue: Palliative care in cancer – creativity and innovation in action

Dr Fiona Rawlinson - Cardiff University School of Medicine, Cardiff, UK
Special Issue: Palliative care in cancer – creativity and innovation in action ( Dr Fiona Rawlinson - Cardiff University School of Medicine, Cardiff, UK )
9 Dec 2024

Breast conserving surgery and IORT can manage locally recurrent breast cancer

Dr Fabiana Gregucci - Weill Cornell Medicine, New York, USA
Breast conserving surgery and IORT can manage locally recurrent breast cancer ( Dr Fabiana Gregucci - Weill Cornell Medicine, New York, USA )
6 Dec 2024

Outcomes of radium-223 and SABR versus SABR for oligometastatic prostate cancers

Dr Ana Kiess - Johns Hopkins University, Baltimore, USA
Outcomes of radium-223 and SABR versus SABR for oligometastatic prostate cancers ( Dr Ana Kiess - Johns Hopkins University, Baltimore, USA )
6 Dec 2024